HECA and hepatocellular carcinoma: The downregulation of HECA homo protein was frequent (71.0%), especially in HCC patients with a poorly differentiated grade, high serum AFP level, liver cirrhosis or large tumor size, all of which are indicators for the poor prognosis of HCC patients.